However, the deregulation of some of the genes involved in Treg modulation, such as NR4A2, BACH2, FOXP3, and PDCD5, have been directly associated with the pathogenesis of MS or HT (14, 16–18, 24, 27, 45–49). This evidence concerns the gene NR4A2 and myeloid sarcoma.